• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-181-5p/KLHL5 通过激活 METTL3 介导的 m6A 过程促进胃癌的增殖和迁移。

miR-181-5p/KLHL5 Promoted Proliferation and Migration of Gastric Cancer Through Activating METTL3-Mediated m6A Process.

机构信息

Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi, 710061, People's Republic of China.

Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi, China.

出版信息

Mol Biotechnol. 2024 Sep;66(9):2415-2425. doi: 10.1007/s12033-023-00877-x. Epub 2023 Sep 21.

DOI:10.1007/s12033-023-00877-x
PMID:37733183
Abstract

KLHL5 was a member of kelch-repeat protein family and was involved in the initiation of progression of a plethora of cancers. However, its specific role in gastric cancer was not explicitly illustrated. In this context, we aimed to investigate the biological role and mechanisms about KLHL5 in gastric cancer. qRT-PCR and western blot were used to investigate the expression of KLHL5 and EMT biomarkers. Wound healing assay, CCK-8, and Transwell assay were used to investigate the biological function of KLHL5. We found that KLHL5 was highly expressed in gastric cancer both in vivo and in vitro; besides, its high expression led to a shorter overall survival. Following statistical analysis showed that KLHL5 was associated with M stage. As for molecular experiments, we found that KLHL5 knockdown significantly reduced the proliferation, migration, and invasion ability of gastric cancer cell line MKN45 and SGC-7901. Furthermore, we found that miR-181-5p targeted KLHL5 to regulate m6A level through METTL3. In addition, KLHL5 knockdown could significantly reduce the lung metastasis rate in mice. In conclusion, we found that miR-181-5p/KLHL5 could promote the proliferation, migration, and invasion of gastric cancer by activating m6A process through regulating METTL3.

摘要

KLHL5 是 kelch 重复蛋白家族的成员,参与了多种癌症的进展的启动。然而,其在胃癌中的具体作用尚未明确说明。在这种情况下,我们旨在研究 KLHL5 在胃癌中的生物学作用和机制。qRT-PCR 和 Western blot 用于研究 KLHL5 和 EMT 生物标志物的表达。伤口愈合试验、CCK-8 和 Transwell 试验用于研究 KLHL5 的生物学功能。我们发现 KLHL5 在体内和体外均在胃癌中高度表达;此外,其高表达导致总生存期缩短。统计分析表明,KLHL5 与 M 期有关。至于分子实验,我们发现 KLHL5 敲低显著降低了胃癌细胞系 MKN45 和 SGC-7901 的增殖、迁移和侵袭能力。此外,我们发现 miR-181-5p 通过 METTL3 靶向 KLHL5 来调节 m6A 水平。此外,KLHL5 敲低可显著降低小鼠的肺转移率。总之,我们发现 miR-181-5p/KLHL5 通过调节 METTL3 激活 m6A 过程,可促进胃癌的增殖、迁移和侵袭。

相似文献

1
miR-181-5p/KLHL5 Promoted Proliferation and Migration of Gastric Cancer Through Activating METTL3-Mediated m6A Process.miR-181-5p/KLHL5 通过激活 METTL3 介导的 m6A 过程促进胃癌的增殖和迁移。
Mol Biotechnol. 2024 Sep;66(9):2415-2425. doi: 10.1007/s12033-023-00877-x. Epub 2023 Sep 21.
2
Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.甲基转移酶样蛋白 3 在食管癌上皮-间质转化过程、侵袭和转移中的作用机制。
Bioengineered. 2021 Dec;12(2):10023-10036. doi: 10.1080/21655979.2021.1994721.
3
Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.EED 通过甲基化 microRNA-338-5p 促进 METTL3 介导的癌基因 CDCP1 在胃癌中的翻译。
Aging (Albany NY). 2021 Apr 21;13(8):12224-12238. doi: 10.18632/aging.103822.
4
N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.N6-甲基腺苷(m6A)介导的长非编码 RNA LINC01320 的上调通过 miR495-5p/RAB19 轴促进胃癌的增殖、迁移和侵袭。
Bioengineered. 2021 Dec;12(1):4081-4091. doi: 10.1080/21655979.2021.1953210.
5
BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification.BUB1 通过 m6A 修饰激活 TRAF6/NF-κB/FGF18 促进胃癌增殖和转移。
Life Sci. 2024 Sep 15;353:122916. doi: 10.1016/j.lfs.2024.122916. Epub 2024 Jul 16.
6
METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.METTL3 介导的 miR-589-5p 成熟促进肝癌的恶性发展。
J Cell Mol Med. 2022 May;26(9):2505-2519. doi: 10.1111/jcmm.16845. Epub 2022 Mar 29.
7
The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.m6A 甲基转移酶 METTL3 介导的 DEK mRNA 的 N6-甲基腺苷化修饰促进胃癌细胞生长和转移。
Int J Mol Sci. 2022 Jun 9;23(12):6451. doi: 10.3390/ijms23126451.
8
c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.c-MYC/METTL3/LINC01006 正反馈环促进非小细胞肺癌的迁移、侵袭和增殖。
Biomed J. 2024 Aug;47(4):100664. doi: 10.1016/j.bj.2023.100664. Epub 2023 Sep 27.
9
METTL3-driven m6A modification of lncRNA FAM230B suppresses ferroptosis by modulating miR-27a-5p/BTF3 axis in gastric cancer.METTL3 驱动的 lncRNA FAM230B 的 m6A 修饰通过调节 miR-27a-5p/BTF3 轴抑制胃癌中的铁死亡。
Biochim Biophys Acta Gen Subj. 2024 Nov;1868(11):130714. doi: 10.1016/j.bbagen.2024.130714. Epub 2024 Sep 14.
10
METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.METTL3通过以m6A依赖的方式调节miR-182成熟来促进前列腺癌进展。
Andrologia. 2022 Aug;54(7):1581-1591. doi: 10.1111/and.14422. Epub 2022 Apr 12.

引用本文的文献

1
METTL3 as a potential therapeutic target in gastric cancer.METTL3作为胃癌潜在的治疗靶点。
Front Oncol. 2024 Nov 29;14:1483435. doi: 10.3389/fonc.2024.1483435. eCollection 2024.
2
METTL3-Regulated lncRNA SNHG7 Drives MNNG-Induced Epithelial-Mesenchymal Transition in Gastric Precancerous Lesions.METTL3调控的长链非编码RNA SNHG7驱动MNNG诱导的胃癌前病变上皮-间质转化
Toxics. 2024 Aug 6;12(8):573. doi: 10.3390/toxics12080573.

本文引用的文献

1
The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study.2020 - 2040年185个国家胃癌的当前及未来发病率和死亡率:一项基于人群的建模研究
EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404. eCollection 2022 May.
2
The role of m6A modification in the biological functions and diseases.m6A 修饰在生物学功能和疾病中的作用。
Signal Transduct Target Ther. 2021 Feb 21;6(1):74. doi: 10.1038/s41392-020-00450-x.
3
SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection.
SHP2 缺乏促进流感感染后继发金黄色葡萄球菌肺炎。
Cell Prolif. 2020 Jan;53(1):e12721. doi: 10.1111/cpr.12721. Epub 2019 Nov 29.
4
FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer.FOXS1 受 GLI1 和 miR-125a-5p 的调控,促进胃癌细胞的增殖和 EMT。
Sci Rep. 2019 Mar 27;9(1):5281. doi: 10.1038/s41598-019-41717-w.
5
EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?局部晚期前列腺癌中的上皮-间质转化标志物:能否预测复发?
Front Oncol. 2019 Mar 11;9:131. doi: 10.3389/fonc.2019.00131. eCollection 2019.
6
Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.NDRG1 的上调通过影响膀胱癌中的 EMT 过程预测不良预后并促进疾病进展。
Sci Rep. 2019 Mar 26;9(1):5166. doi: 10.1038/s41598-019-41660-w.
7
MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers.MEST 通过激活 STAT3 诱导乳腺癌中的 Twist-1 介导的 EMT。
Cell Death Differ. 2019 Dec;26(12):2594-2606. doi: 10.1038/s41418-019-0322-9. Epub 2019 Mar 22.
8
KLHL5 knockdown increases cellular sensitivity to anticancer drugs.KLHL5基因敲低可增加细胞对抗癌药物的敏感性。
Oncotarget. 2018 Dec 21;9(100):37429-37438. doi: 10.18632/oncotarget.26462.
9
Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.KLHL3表达降低参与体内由cullin 3突变引起的II型假性醛固酮增多症的发病机制。
Clin Exp Nephrol. 2018 Dec;22(6):1251-1257. doi: 10.1007/s10157-018-1593-z. Epub 2018 Jun 5.
10
Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation.抑制 KLHL21 通过调节细胞增殖和运动、阻滞细胞周期和减少 Erk 激活来阻止胆管癌进展。
Biochem Biophys Res Commun. 2018 May 15;499(3):433-440. doi: 10.1016/j.bbrc.2018.03.152. Epub 2018 Mar 31.